Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 May:79:104006.
doi: 10.1016/j.ebiom.2022.104006. Epub 2022 Apr 14.

Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine

Beatrice Francavilla  1 , Marzia Nuccetelli  2 , Mariapia Guerrieri  3 , Denise Fiorelli  2 , Stefano Di Girolamo  3
Affiliations
Comment

Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine

Beatrice Francavilla et al. EBioMedicine. 2022 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests All authors disclose no financial and personal relationships with other people or organizations that could inappropriately influence their work.

Comment in

Comment on

  • Mucosal immune response in BNT162b2 COVID-19 vaccine recipients.
    Azzi L, Dalla Gasperina D, Veronesi G, Shallak M, Ietto G, Iovino D, Baj A, Gianfagna F, Maurino V, Focosi D, Maggi F, Ferrario MM, Dentali F, Carcano G, Tagliabue A, Maffioli LS, Accolla RS, Forlani G. Azzi L, et al. EBioMedicine. 2022 Jan;75:103788. doi: 10.1016/j.ebiom.2021.103788. Epub 2021 Dec 23. EBioMedicine. 2022. PMID: 34954658 Free PMC article. Clinical Trial.

References

    1. Azzi L., Dalla Gasperina D., Veronesi G., et al. Mucosal immune response in BNT162b2 COVID-19 vaccine recipients. eBioMedicine. 2022;75 doi: 10.1016/j.ebiom.2021.103788. - DOI - PMC - PubMed
    1. Ketas T.J., Chaturbhuj D., Cruz Portillo V.M., et al. Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva. PAI. 2021;6(1):116–134. doi: 10.20411/pai.v6i1.441. - DOI - PMC - PubMed
    1. Becker M., Dulovic A., Junker D., et al. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals. Nat Commun. 2021;12(1):3109. doi: 10.1038/s41467-021-23473-6. - DOI - PMC - PubMed
    1. Pinilla Y.T., Heinzel C., Caminada L.F., et al. SARS-CoV-2 antibodies are persisting in saliva for more than 15 months after infection and become strongly boosted after vaccination. Front Immunol. 2021;12 doi: 10.3389/fimmu.2021.798859. - DOI - PMC - PubMed
    1. Guerrieri M., Francavilla B., Fiorelli D., et al. Nasal and salivary mucosal humoral immune response elicited by mRNA BNT162b2 COVID-19 vaccine compared to SARS-CoV-2 natural infection. Vaccines. 2021;9(12):1499. doi: 10.3390/vaccines9121499. - DOI - PMC - PubMed